Arc Institute Welcomes Metagenomi's Megan van Overbeek as First Chief Scientific Officer

Arc has reached another institutional milestone—a full leadership team—with the appointment of Megan van Overbeek, PhD, as our first Chief Scientific Officer. In this role, Megan will drive the discovery and development of novel therapeutic strategies for complex diseases. She will also oversee the coordination of four of Arc’s five Technology Centers to advance the Institute’s Virtual Cell and Alzheimer's Disease Initiatives.

arcinstitute.org/...